Cancer prevention is no longer just a personal battle—it's a political imperative. And the European Code Against Cancer (ECAC) has finally caught up to this reality. After over a decade, the 5th edition (ECAC5) arrives at a critical juncture, as cancer remains a leading cause of premature death in Europe, fueled by preventable risk factors embedded in our daily lives. This update isn't just about new scientific findings; it's a paradigm shift, moving cancer prevention from individual responsibility to a shared societal and political duty. [https://cancer-code-europe.iarc.who.int/]
The European Public Health Alliance (EPHA) enthusiastically welcomes ECAC5 [https://www.iarc.who.int/news-events/reducing-cancer-risk-through-science-the-evidence-base-behind-the-european-code-against-cancer-5th-edition-described-in-two-new-publications] for its bold approach. For the first time, the Code directly addresses policymakers, acknowledging that individual choices are shaped and limited by policies, commercial influences, and environmental factors. This is a game-changer, moving beyond simply advising individuals to a framework that demands systemic change.
But here's where it gets controversial: ECAC5 doesn't just expand on previous recommendations (now 14 instead of 12); it introduces a parallel set of guidelines specifically for policymakers [https://cancer-code-europe.iarc.who.int/wp-content/uploads/2025/10/European-Code-Against-Cancer-5th-edition.pdf]. It explicitly states that prevention relies on structural changes: regulations, taxes, public investment, and protection from harmful commercial practices. This challenges the long-held belief that awareness campaigns and individual behavior change are enough.
The updated Code reflects the evolving landscape of cancer risk. It tackles vaping and new nicotine products head-on, reinforces the message to avoid alcohol entirely, strengthens guidance on diet, obesity, and ultra-processed foods, and expands HPV vaccination to all genders. Crucially, it highlights environmental risk factors like radon, sun exposure, and occupational carcinogens, while introducing a new recommendation on tackling air pollution, a major cancer driver.
And this is the part most people miss: ECAC5 isn't just about cancer. It aligns cancer prevention with the fight against other non-communicable diseases (NCDs) like heart disease and diabetes. By targeting shared risk factors like tobacco use, unhealthy diets, and physical inactivity, ECAC5 strengthens integrated NCD prevention efforts, maximizing health gains and optimizing public resources. This aligns perfectly with WHO's "best buys" and "quick buys" for NCD prevention [https://www.who.int/news/item/26-05-2023-more-ways--to-save-more-lives--for-less-money----world-health-assembly-adopts-more-best-buys--to-tackle-noncommunicable-diseases, https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(25)00073-0/fulltext] and the EU's Safe Hearts Plan [https://epha.org/framing-action-for-cardiovascular-health-in-europe-reflections-on-the-new-eu-safe-hearts-plan/].
From EPHA's perspective, the policy recommendations are the true breakthrough. They translate scientific evidence into clear expectations for governments: regulate harmful products, curb aggressive marketing, ensure clean air and safe workplaces, invest in vaccination and screening, and design health-promoting food, transport, and urban systems.
Importantly, ECAC5 addresses equity and integrity. It recognizes that cancer risk is not evenly distributed and that prevention policies must reduce, not worsen, health inequalities. It also emphasizes the need to shield public health policy from commercial interference, crucial for effective regulation of industries like tobacco, alcohol, and ultra-processed foods.
By doing so, ECAC5 shifts the focus from individual blame to public accountability. It makes it clear that failing to prevent cancer is a political failure, not just a matter of personal choice.
EPHA is proud to have contributed to ECAC5's development [https://www.sciencedirect.com/science/article/pii/S2666776226000049], with our Director General participating in the expert group alongside leading scientists coordinated by the International Agency for Research on Cancer (IARC). This highlights the vital role of independent public health and civil society voices in shaping evidence-based prevention strategies.
We strongly agree with the European Cancer League [https://www.cancer.eu/european-code-against-cancer/]: ECAC5 must be more than a document; it should be a practical policy tool. Its success will be measured not by downloads or endorsements, but by its translation into concrete action at EU, national, and local levels.
ECAC5 sends a clear message: cancer prevention requires political leadership, regulatory courage, and sustained investment. As Europe debates its health priorities, the Code offers a scientifically sound and politically relevant roadmap for prevention that benefits not only cancer outcomes but also NCD control and overall population health. ECAC5 leaves policymakers with fewer excuses and a clearer responsibility to act.
Do you think ECAC5 goes far enough? What role should individuals and governments play in cancer prevention? Share your thoughts in the comments below.
